Skip to main content
logo
China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.9800
-0.0800 (-7.55%)
Aug 21, 2026, 4:00 PM EDT - Market closed

China Pharma Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.914.144.537.018.19.64
Revenue Growth
-10.97%-8.49%-35.41%-13.48%-15.95%-11.27%
Cost of Revenue
3.454.286.517.298.69.29
Gross Profit
0.46-0.13-1.99-0.28-0.490.35
Selling, General & Admin
4.52.832.312.252.963.15
Research & Development
0.330.130.280.240.190.32
Operating Expenses
4.842.962.62.473.063.21
Operating Income
-4.38-3.09-4.59-2.75-3.55-2.86
Interest Expense
-0.1-0.1-0.15-0.33-0.43-0.54
Interest & Investment Income
000.010.010.010
EBT Excluding Unusual Items
-4.47-3.19-4.74-3.08-3.97-3.4
Pretax Income
-4.47-3.19-4.74-3.08-3.97-3.4
Net Income
-4.47-3.19-4.74-3.08-3.97-3.4
Net Income to Common
-4.47-3.19-4.74-3.08-3.97-3.4
Net Income Growth
------
Shares Outstanding (Basic)
2042000
Shares Outstanding (Diluted)
2042000
Shares Change
646.10%145.73%416.13%221.82%13.96%5.75%
EPS (Basic)
-0.23-0.74-2.71-9.10-37.79-36.85
EPS (Diluted)
-0.23-0.74-2.71-9.10-37.79-36.85
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.160.09-0.44-0.71-0.81-0.69
Free Cash Flow Per Share
-0.010.02-0.26-2.10-7.72-7.46
Gross Margin
11.76%-3.18%-43.84%-4.01%-6.09%3.62%
Operating Margin
-111.82%-74.50%-101.32%-39.25%-43.79%-29.67%
Profit Margin
-114.33%-76.92%-104.58%-43.91%-49.02%-35.26%
Free Cash Flow Margin
-4.04%2.15%-9.81%-10.14%-10.01%-7.13%
EBITDA
-1.44-1.58-1.970-0.850.23
EBITDA Margin
-36.81%-38.22%-43.52%0.03%-10.47%2.36%
D&A For EBITDA
2.941.52.622.752.73.09
EBIT
-4.38-3.09-4.59-2.75-3.55-2.86
EBIT Margin
-111.82%-74.50%-101.32%-39.25%-43.79%-29.67%
SEC Filings: 10-K · 10-Q